The Senior Scientist Research and Mentorship Award is targeted for "outstanding senior scientists who have demonstrated a sustained level of high productivity conducting biomedical research" in order to protect their time to continue research while mentoring the "next generation" of investigators. With more than 25 years of experience in clinical alcohol research (over 20 clinical trials, seminal work in craving (OCDS), biomarkers of drinking (CDT), neuroimaging, and more recently in genetic and pharmacogenomics), over 15 years of continued R01 funding, 16 years of being a Scientific Director of an Alcohol Research Center, with 245 peer reviewed publications, and international recognition, the candidate meets and exceeds the requirements as an outstanding senior scientist. He has been elected to high leadership positions of leading academic/research societies, a previous leader of the COMBINE Study, and is sought out as a mentor for his expertise in bridging the gap between basic and clinical research. He has accomplished this while maintaining an active training program in alcohol research, including 20 years as Director or Co-Director of an NIAAA-sponsored T32 Research Training Grant. He has personally mentored 34 professionals (23 MDs and 11 PhDs), 20 of those in the past 4 years. Many have secured career development and independent alcohol research funding and remain tied to the alcohol field. His understanding of both the mechanisms of, and applications to, the treatment of alcohol disorders is atypical and rare. This award is important to the candidate for two major reasons. First, it will provide him with protected time to keep his alcohol research career on the cutting edge by enabling him to continue formal and informal training in genetics (e.g. epigenetics), proteomics (e.g. glycoproteomics), and new/advanced neuroimaging skills (fMRI connectivity analysis, diffusion kurtosis, and H1-magnetic resonance spectroscopy), apply these essential areas of science to his own alcohol research (as outlined), and communicate new discoveries to the alcohol treatment field in general. Second, this award will provide the candidate with protected time from additional clinical and administrative duties to apply his vast experience and newly acquired skills to his mentoring activities and the development of younger clinical- scientists. With the NIH and the American Association of Medical Colleges highlighting the large, unmet need in the U.S. for clinical and translational researchers (especially in the area of genomics) and with millions of Americans suffering from alcohol disorders, who are underserved and who cost the US economy over $200 billion each year, there is a need to push clinical research forward, a need to ensure our senior scientists are on the cutting edge in their own research, and a need to train future scientists to carry on this research to find effective treatments. This K05 Senior Scientist Career and Mentoring Award will allow this to happen.

Public Health Relevance

Genomics, Proteomics and Neuroimaging technologies have opened new vistas for advancing the understanding of the biology of alcohol effects and alcohol dependence in humans. This K05 award will allow a preeminent alcohol research clinical scientist to gain new skills in these areas and to mentor the next generation of alcohol clinical and translational researchers.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Scientist Award (K05)
Project #
2K05AA017435-06
Application #
8509462
Study Section
Health Services Research Review Subcommittee (AA)
Program Officer
Roach, Deidra
Project Start
2008-06-05
Project End
2018-05-31
Budget Start
2013-08-01
Budget End
2014-05-31
Support Year
6
Fiscal Year
2013
Total Cost
$216,225
Indirect Cost
$16,017
Name
Medical University of South Carolina
Department
Psychiatry
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Weykamp, Cas; Wielders, Jos; Helander, Anders et al. (2014) Harmonization of measurement results of the alcohol biomarker carbohydrate-deficient transferrin by use of the toolbox of technical procedures of the International Consortium for Harmonization of Clinical Laboratory Results. Clin Chem 60:945-53
Falk, Daniel E; Litten, Raye Z; Anton, Raymond F et al. (2014) Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trials. J Stud Alcohol Drugs 75:335-46
Ray, Lara A; Bujarski, Spencer; Squeglia, Lindsay M et al. (2014) Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol Alcohol 49:261-70
Schacht, Joseph P; Anton, Raymond F; Randall, Patrick K et al. (2014) Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals. Psychopharmacology (Berl) 231:3799-807
Anton, Raymond F (2014) Commentary on: ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials. Alcohol Clin Exp Res 38:1826-8
Stewart, Scott H; Koch, David G; Willner, Ira R et al. (2014) Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease. Alcohol Clin Exp Res 38:1706-11
Schacht, Joseph P; Anton, Raymond F; Randall, Patrick K et al. (2013) Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics. Psychopharmacology (Berl) 227:627-37
Schacht, Joseph P; Anton, Raymond F; Voronin, Konstantin E et al. (2013) Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology 38:414-22
Zhang, Huiping; Herman, Aryeh I; Kranzler, Henry R et al. (2013) Array-based profiling of DNA methylation changes associated with alcohol dependence. Alcohol Clin Exp Res 37 Suppl 1:E108-15
Leventhal, Adam M; Gelernter, Joel; Oslin, David et al. (2011) Agitated depression in substance dependence. Drug Alcohol Depend 116:163-9

Showing the most recent 10 out of 22 publications